rs45517141

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000548.5(TSC2):​c.948G>A​(p.Pro316Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000688 in 1,607,610 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P316P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0034 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00040 ( 3 hom. )

Consequence

TSC2
NM_000548.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:18O:1

Conservation

PhyloP100: -2.13

Publications

10 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 16-2058846-G-A is Benign according to our data. Variant chr16-2058846-G-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 49395.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.13 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00343 (523/152310) while in subpopulation AFR AF = 0.0121 (502/41568). AF 95% confidence interval is 0.0112. There are 3 homozygotes in GnomAd4. There are 236 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 523 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000548.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
NM_000548.5
MANE Select
c.948G>Ap.Pro316Pro
synonymous
Exon 10 of 42NP_000539.2P49815-1
TSC2
NM_001406663.1
c.948G>Ap.Pro316Pro
synonymous
Exon 10 of 42NP_001393592.1A0A2R8Y6C9
TSC2
NM_001114382.3
c.948G>Ap.Pro316Pro
synonymous
Exon 10 of 41NP_001107854.1P49815-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TSC2
ENST00000219476.9
TSL:5 MANE Select
c.948G>Ap.Pro316Pro
synonymous
Exon 10 of 42ENSP00000219476.3P49815-1
TSC2
ENST00000350773.9
TSL:1
c.948G>Ap.Pro316Pro
synonymous
Exon 10 of 41ENSP00000344383.4P49815-4
TSC2
ENST00000401874.7
TSL:1
c.948G>Ap.Pro316Pro
synonymous
Exon 10 of 40ENSP00000384468.2P49815-5

Frequencies

GnomAD3 genomes
AF:
0.00344
AC:
524
AN:
152192
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000916
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.000849
AC:
203
AN:
239038
AF XY:
0.000557
show subpopulations
Gnomad AFR exome
AF:
0.0113
Gnomad AMR exome
AF:
0.000599
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000837
Gnomad OTH exome
AF:
0.000338
GnomAD4 exome
AF:
0.000401
AC:
583
AN:
1455300
Hom.:
3
Cov.:
32
AF XY:
0.000358
AC XY:
259
AN XY:
723158
show subpopulations
African (AFR)
AF:
0.0118
AC:
394
AN:
33440
American (AMR)
AF:
0.000570
AC:
25
AN:
43864
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25892
East Asian (EAS)
AF:
0.0000758
AC:
3
AN:
39600
South Asian (SAS)
AF:
0.0000236
AC:
2
AN:
84622
European-Finnish (FIN)
AF:
0.0000189
AC:
1
AN:
52846
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5754
European-Non Finnish (NFE)
AF:
0.0000956
AC:
106
AN:
1109088
Other (OTH)
AF:
0.000847
AC:
51
AN:
60194
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
36
73
109
146
182
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00343
AC:
523
AN:
152310
Hom.:
3
Cov.:
33
AF XY:
0.00317
AC XY:
236
AN XY:
74484
show subpopulations
African (AFR)
AF:
0.0121
AC:
502
AN:
41568
American (AMR)
AF:
0.000915
AC:
14
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68030
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
27
54
80
107
134
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00147
Hom.:
4
Bravo
AF:
0.00402
Asia WGS
AF:
0.000866
AC:
3
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not specified (5)
-
-
4
Tuberous sclerosis 2 (4)
-
-
3
not provided (3)
-
-
2
Hereditary cancer-predisposing syndrome (2)
-
-
2
Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1860707:Tuberous sclerosis 2 (2)
-
-
2
Tuberous sclerosis syndrome (3)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
0.23
DANN
Benign
0.46
PhyloP100
-2.1
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45517141; hg19: chr16-2108847; COSMIC: COSV104375872; API